Alto Neuroscience to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Alto Neuroscience, Inc. (ANRO) announced its participation in upcoming investor conferences, including Jefferies Biotech on the Bay Summit, UBS Virtual CNS Day, and Stifel 2024 Virtual CNS Days. Dr. Amit Etkin, the CEO, will be engaging in one-on-one meetings and fireside chats during the conferences, providing investors with valuable insights.

LOS ALTOS, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced that company management will participate in the following upcoming investor conferences:

• Jefferies Biotech on the Bay Summit, March 12-13^th: Alto management will participate in one-on-one meetings with investors during the conference.
• UBS Virtual CNS Day, March 18^th: Amit Etkin, M.D., Ph.D., founder and chief executive officer, will participate in a fireside chat on Monday, March 18, 2024, at 2:30 pm ET.
• Stifel 2024 Virtual CNS Days, March 19-20^th: Dr. Etkin will participate in a fireside chat on Wednesday, March 20, 2024, at 11:30 am ET. Alto management will also participate in one-on-one meetings with investors during the conference.

The fireside chats will be available via live webcast on the Events and Presentations page in the Investors section of Alto’s website and a replay will be available following the presentation.

About Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto’s Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions. For more information, visit www.altoneuroscience.com or follow Alto on X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240307562812/en/

Investor Contact:

Nick Smith

investors@altoneuroscience.com

Media Contact:

Jordann Merkert

media@altoneuroscience.com

Source: Alto Neuroscience, Inc.

FAQ

When is Amit Etkin participating in a fireside chat at UBS Virtual CNS Day?

Amit Etkin will participate in a fireside chat on Monday, March 18, 2024, at 2:30 pm ET.

Where can investors watch the fireside chats live?

The fireside chats will be available via live webcast on the Events and Presentations page in the Investors section of Alto’s website.

Which conferences will Alto management participate in?

Alto management will participate in Jefferies Biotech on the Bay Summit, UBS Virtual CNS Day, and Stifel 2024 Virtual CNS Days, engaging in one-on-one meetings with investors.

Will there be a replay available for the fireside chats?

Yes, a replay will be available following the presentation on Alto's website.

Who is the founder and CEO of Alto Neuroscience, Inc.?

Dr. Amit Etkin, M.D., Ph.D., is the founder and chief executive officer of Alto.